• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inappropriate Utilization of Antibiotics in COPD Exacerbations.慢性阻塞性肺疾病急性加重期抗生素的不恰当使用
Turk Thorac J. 2020 Nov;21(6):397-403. doi: 10.5152/TurkThoracJ.2020.19074. Epub 2020 Nov 1.
2
In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study.院内抗生素治疗严重慢性阻塞性肺疾病加重的回顾性观察研究。
BMC Pulm Med. 2023 Apr 25;23(1):138. doi: 10.1186/s12890-023-02426-3.
3
Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.基层医疗中慢性阻塞性肺疾病急性加重期抗生素处方及痰培养诊断的真实世界数据。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 13;12:285-290. doi: 10.2147/COPD.S120510. eCollection 2017.
4
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.低剂量茶碱口服联合吸入皮质激素治疗慢性阻塞性肺疾病且有加重高风险的患者:一项 RCT 研究。
Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.
5
Procalcitonin-Guided Antibiotic Prescribing for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department.急诊科慢性阻塞性肺疾病急性加重期降钙素原指导下的抗生素处方
Fed Pract. 2021 Jun;38(6):264-269. doi: 10.12788/fp.0141.
6
Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines Initiative.抗生素治疗对门诊急性 COPD 加重的真实世界影响:PharmLines 计划下的一项队列研究。
Respiration. 2022;101(6):553-564. doi: 10.1159/000520884. Epub 2022 Jan 3.
7
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
8
The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study.呼吸道病毒检测 panel 对因轻至中度 COPD 急性加重而入院患者出院时抗生素处方模式的影响:一项回顾性前后研究。
BMC Pulm Med. 2019 Jul 1;19(1):118. doi: 10.1186/s12890-019-0872-0.
9
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
10
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.全科医疗中慢性阻塞性肺疾病及其急性加重的治疗。EOLO 研究组。气道阻塞受限的观察性研究。
Respir Med. 1999 Mar;93(3):173-9. doi: 10.1016/s0954-6111(99)90004-5.

引用本文的文献

1
Healthcare worker views on antimicrobial resistance in chronic respiratory disease.医护人员对慢性呼吸道疾病中抗菌药物耐药性的看法。
Antimicrob Resist Infect Control. 2025 Jan 22;14(1):1. doi: 10.1186/s13756-025-01515-8.
2
Short-acting beta agonist, antibiotics, oral corticosteroid and association with mortality and cardiopulmonary events in patients with COPD: a retrospective cohort study in Alberta, Canada.短效β受体激动剂、抗生素、口服糖皮质激素与慢性阻塞性肺疾病患者的死亡率及心肺事件的相关性:加拿大艾伯塔省的一项回顾性队列研究
BMJ Open. 2025 Jan 22;15(1):e083451. doi: 10.1136/bmjopen-2023-083451.
3
Overuse of medications in low- and middle-income countries: a scoping review.中低收入国家药物的过度使用:范围综述。
Bull World Health Organ. 2023 Jan 1;101(1):36-61D. doi: 10.2471/BLT.22.288293. Epub 2022 Oct 31.
4
Antibiotics Use among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study.内科慢性阻塞性肺疾病急性加重患者抗生素使用情况:一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2022 Jun 1;60(250):541-545. doi: 10.31729/jnma.7512.
5
Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.鞘氨醇-1-磷酸和 CRP 作为潜在的联合生物标志物在鉴别 COPD 合并社区获得性肺炎和 COPD 急性加重中的作用。
Respir Res. 2022 Mar 20;23(1):63. doi: 10.1186/s12931-022-01991-1.

本文引用的文献

1
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.C 反应蛋白检测指导 COPD 加重期抗生素的使用。
N Engl J Med. 2019 Jul 11;381(2):111-120. doi: 10.1056/NEJMoa1803185.
2
Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.在初级保健中,有症状的吸烟者和戒烟者中 COPD 的预测因素。
Chron Respir Dis. 2018 Nov;15(4):393-399. doi: 10.1177/1479972318761655. Epub 2018 Feb 27.
3
[Polypharmacy and drug interactions in elderly patients].[老年患者的多重用药与药物相互作用]
Turk Kardiyol Dern Ars. 2017 Sep;45(Suppl 5):17-21. doi: 10.5543/tkda.2017.92770.
4
Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study.慢性阻塞性肺疾病急性加重的危险因素:一项前瞻性研究。
Int J Tuberc Lung Dis. 2016 Mar;20(3):389-95. doi: 10.5588/ijtld.15.0441.
5
Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.基层医疗中哮喘和慢性阻塞性肺疾病急性加重期使用抗生素和全身糖皮质激素治疗的预测因素。
BMC Fam Pract. 2015 Mar 24;16:40. doi: 10.1186/s12875-015-0256-3.
6
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.一项随机双盲安慰剂对照研究,旨在证明慢性阻塞性肺疾病中度急性加重期无需使用抗生素——ABACOPD研究。
BMC Pulm Med. 2015 Jan 27;15:5. doi: 10.1186/1471-2466-15-5.
7
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD.C 反应蛋白水平与 COPD 急性加重期住院患者的微生物病因。
Eur Respir J. 2015 Jan;45(1):76-86. doi: 10.1183/09031936.00092214. Epub 2014 Sep 3.
8
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.抗生素治疗和预防慢性阻塞性肺疾病加重。
J Infect. 2013 Dec;67(6):497-515. doi: 10.1016/j.jinf.2013.08.010. Epub 2013 Aug 22.
9
C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.C 反应蛋白水平可预测慢性阻塞性肺疾病患者的细菌恶化。
Am J Med Sci. 2013 Mar;345(3):190-4. doi: 10.1097/MAJ.0b013e318253c921.
10
Drug interactions--principles, examples and clinical consequences.药物相互作用——原理、实例及临床后果。
Dtsch Arztebl Int. 2012 Aug;109(33-34):546-55; quiz 556. doi: 10.3238/arztebl.2012.0546. Epub 2012 Aug 20.

慢性阻塞性肺疾病急性加重期抗生素的不恰当使用

Inappropriate Utilization of Antibiotics in COPD Exacerbations.

作者信息

Varol Yelda, Karakurt Zuhal, Çırak Ali Kadri, Şahin Hülya Doğan, Kıraklı Cenk, Kömürcüoğlu Berna

机构信息

Department of Pulmonology, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.

Department of Pulmonology, University of Health Sciences, Süreyyapasa Chest Diseases and Surgery Training and Research Hospital, İstanbul, Turkey.

出版信息

Turk Thorac J. 2020 Nov;21(6):397-403. doi: 10.5152/TurkThoracJ.2020.19074. Epub 2020 Nov 1.

DOI:10.5152/TurkThoracJ.2020.19074
PMID:33352095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7752103/
Abstract

OBJECTIVE

Most exacerbations are mild to moderate, and antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is recommended for patients with severe exacerbations or severe underlying chronic obstructive pulmonary disease (COPD). Therefore, we aimed to investigate the patient factors that are associated with the prescription of antibiotics for inappropriate indication in AECOPD.

MATERIAL AND METHODS

This study was an observational cross-sectional study conducted in an outpatient clinic. The patients diagnosed with AECOPD and prescribed an antibiotic by a pulmonary physician were enrolled in the study. These prescriptions were documented by the pharmacist who asked the patient about the three cardinal symptoms. Appropriate and inappropriate prescription groups were defined by the types of exacerbations, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD report.

RESULTS

There were 138 patients, predominantly male (83%), with a mean age of 64 (±9) years. A total of 64% of the prescriptions were appropriate; however, there were 50 (36%) patients with inappropriate antibiotic prescription according to the mentioned criteria. When we compared the patient factors between the appropriate and inappropriate antibiotic prescriptions, there was no statistically significant difference in terms of age, Forced expiratory volume in first second % (FEV1%) predicted, FEV1 ml, forced vital capacity (FVC) ml, FEV1/FVC, and amount (packs/year) of smoking (p>0.05 for all parameters). FVC% was statistically significantly lower in the appropriate antibiotic prescription group compared with that in the inappropriate antibiotic prescription group (p=0.049).

CONCLUSION

This study shows that most pulmonary physicians have a tendency to prescribe antibiotics for AECOPD according to the defined GOLD criteria. However, some of the physicians also prefer to prescribe antibiotics self-directedly, irrespective of the GOLD criteria. A physician-based questionnaire can be completed for future studies to define the underlying reasons for antibiotic prescription demands for cases of mild AECOPD.

摘要

目的

大多数加重情况为轻度至中度,对于重度加重或患有严重基础慢性阻塞性肺疾病(COPD)的慢性阻塞性肺疾病急性加重(AECOPD)患者,建议使用抗生素治疗。因此,我们旨在调查与AECOPD中不适当适应症抗生素处方相关的患者因素。

材料与方法

本研究是在门诊进行的一项观察性横断面研究。纳入了被诊断为AECOPD并由肺科医生开具抗生素处方的患者。这些处方由药剂师记录,药剂师询问了患者三个主要症状。根据慢性阻塞性肺疾病全球倡议(GOLD)COPD报告所定义的加重类型,确定适当和不适当的处方组。

结果

共有138例患者,以男性为主(83%),平均年龄64(±9)岁。共有64%的处方是适当的;然而,根据上述标准,有50例(36%)患者的抗生素处方不适当。当我们比较适当和不适当抗生素处方之间的患者因素时,在年龄、第一秒用力呼气容积百分比(FEV1%)预测值、FEV1毫升、用力肺活量(FVC)毫升、FEV1/FVC以及吸烟量(包/年)方面,没有统计学上的显著差异(所有参数p>0.05)。与不适当抗生素处方组相比,适当抗生素处方组的FVC%在统计学上显著更低(p=0.049)。

结论

本研究表明,大多数肺科医生倾向于根据既定的GOLD标准为AECOPD开具抗生素。然而,一些医生也倾向于自行开具抗生素,而不顾及GOLD标准。未来的研究可以完成一份基于医生的问卷,以确定轻度AECOPD病例抗生素处方需求的潜在原因。